Chorionic Gonadotropin Market By Type (Human Chorionic Gonadotropin (HCG), Animal Chorionic Gonadotropin), By Application (Research institutions, Pharmaceutical), By technology (Natural source extraction, Recombinant DNA technology), By therapeutic area (Female infertility treatment, Oligospermia treatment, Cryptorchidism treatment), Industry Trends, Estimation & Forecast, 2017-2025
- Published Date: 2020-11-27
- Report ID: 22597
- Pages: 150
-
Format:
The research report offers a comprehensive picture of the Chorionic Gonadotropin market. The report initiates with the executive summary of the market that includes market definition, recent industry trends, and developments, strategies of the key players and wide product offerings. Moreover, the study explains the future opportunities and a sketch of the key participants actively operating in the market.
About Chorionic Gonadotropin Market
Chorionic gonadotropin is similar to luteinizing hormone (LH) in function, which is secreted by placenta while the embryo is developing during the pregnancy. This hormone, when administrated with combination of other drugs, helps women to conceive. Apart from that, chorionic gonadotropin along with LH stimulates the production of testosterone in males. Increasing infertility rates worldwide is the major factor which is driving the growth of chorionic gonadotropin market. As per the statistics declared by Maternal Health Task Force, today, infertility is experienced by approximately 50 million couples all around the world. Other factors which are contributing to the market growth include changing lifestyle, increasing maternity age, oligospermia, hormonal dysfunctions in both men and women, and tilting orientation of people towards hormonal drug therapies.
The research report is prepared based on the combination of qualitative as well as quantitative aspects. By thorough understanding, the report is fragmented by larger ratios. The report covers in-depth analysis with major factors such as drivers, restraints, opportunities, and challenges that influences the growth of the market. On the other hand, The Chorionic Gonadotropin report presents data starting from the base year 2018, historical year: 2014-2018, estimated the year 2019 and Forecast year from 2019 to 2026.
The Chorionic Gonadotropin market report offers the market size and estimates the forecast from 2019-2026. The forecast estimation is predicted based on the key regions that include North America, Europe, Asia Pacific, Middle East, South America, and the Middle East & Africa. Furthermore, the Chorionic Gonadotropin report provides a deep emphasis on secondary tools used to document the report. PEST analysis, SWOT, Porters Five Forces, and others are considered by the analysts while preparing the report.
Scope and Segmentation of the Market
Based on Type
Human Chorionic Gonadotropin (HCG)
Animal Chorionic Gonadotropin
Based on Application
Female infertility treatment
Oligospermia treatment
Cryptorchidism treatment
Others
Each segment of the Chorionic Gonadotropin market is extensively evaluated in the research study. The segment analysis covered in the report aims at the key opportunities available in the Chorionic Gonadotropin market report by leading segments. In addition, the research report offers market dynamics for the market that influences qualitative as well as quantitative research.
Research Methodology
The report follows a comprehensive and rigorous research methodology to provide you accurate estimates and forecasts of a particular market. The report provide estimates, forecast, and analysis primarily based on secondary research, primary interviews, in-house database and other free as well as paid sources. In addition, the research methodology we follow is a systematic approach in order to estimate and project the market sizing keeping in mind all the ongoing and upcoming trends of the market.
Competitive Landscape
Key players profiled in this report include (Sales Revenue, Price, Gross Margin, Main Products, etc.):
EMD Serono
Inc.
Ferring B.V.
Merck & Co.
Inc.
Bristol Myers Squibb Company
Fresenius KabiUSA
LLC.
Scrippslabs
Leebio
Kamiya Biomedical Company
Cigna
Sanzyme
Through the successive chapters on the company, profiles provide deep insights on players operating in the Chorionic Gonadotropin market. It focuses on the financial outlook of the key players, the status of R&D, strategies adopted, expansion strategies, and many more. Analysts preparing the report have offered a detailed list of the strategic initiatives adopted by the Chorionic Gonadotropin market participants by referring past records and designing strategies to be adopted in the coming years. This enables the key players to stay ahead in the competition.
Regional Landscape
The chapter on regional segmentation details the regional aspects of the Chorionic Gonadotropin market. This chapter explains the regulatory framework that is likely to impact the overall market. It highlights the political scenario in the market and anticipates its influence on the Chorionic Gonadotropin market. Moreover, the report focuses on value and volume at the regional level, company level, and level.
Chapters covered under this report include:
Chapter 1, describes the Chorionic Gonadotropin market reports - market overview, executive summary, and market scope. Further, the report adds a support base to identify the information and pick in relation to the aforementioned market
Chapter 2, defines the research methodology based on primary as well as secondary research, secondary data sources, and assumptions & exclusions
Chapter 3, description of Chorionic Gonadotropin market in terms of its product scope, opportunities, drivers, restraints, and market risks
Chapter 4, the report offers a company profile of the top manufacturers of Chorionic Gonadotropin market with its sales, revenue, share, and others
Chapter 5 and 6, to narrow down the sales data at the country level with shares, revenue, sand sales from 2018-2026
Chapter 7, the Chorionic Gonadotropin market data is published based on a regional level and to show the revenue, sales, and growth on basis of the base year 2018, historical year: 2014-2018, estimated the year 2019 and Forecast year from 2019 to 2026
Chapter 8, describes the Chorionic Gonadotropin market sales channels, distributors, research findings, appendix, and among others.
CHAPTER 1.INTRODUCTION
1.1.RESEARCH METHODOLOGY
1.1.1.ERC desk research
1.1.2.ERC data synthesis
1.1.3.Data validation and market feedback
1.1.4.ERC data sources
CHAPTER 2.CHORIONIC GONADOTROPIN MARKET OVERVIEW
2.1.CHORIONIC GONADOTROPIN MARKET INTRODUCTION
2.2.GLOBAL CHORIONIC GONADOTROPIN MARKET PRODUCTION AND GROWTH RATE, 2017-2025
2.2.1.Global Chorionic Gonadotropin Production (VOLUME) and Growth Rate (%), (2017-2025)
2.3.GLOBAL CHORIONIC GONADOTROPIN MARKET CAPACITY AND GROWTH RATE, 2017-2025
2.3.1.Global Chorionic Gonadotropin Capacity (VOLUME) and Growth Rate (%), (2017-2025)
2.4.GLOBAL CHORIONIC GONADOTROPIN MARKET REVENUE AND GROWTH RATE, 2017-2025
2.4.1.Global Chorionic Gonadotropin Market Revenue (Million USD) and Growth Rate (%), (2017-2025)
2.5.GLOBAL CHORIONIC GONADOTROPIN MARKET CONSUMPTION AND GROWTH RATE, 2017-2025
2.5.1.Global Chorionic Gonadotropin Consumption (VOLUME) and Growth Rate (%), (2017-2025)
CHAPTER 3.GLOBAL CHORIONIC GONADOTROPIN MARKET BY TYPE, 2017-2025
3.1.HUMAN CHORIONIC GONADOTROPIN (HCG)
3.2.ANIMAL CHORIONIC GONADOTROPIN
3.3.GLOBAL CHORIONIC GONADOTROPIN MARKET REVENUE BY TYPE, 2017-2025
3.3.1.Global Chorionic Gonadotropin Market Revenue (Million USD) and Share (%) By Type, 2017-2025
3.3.2.Human Chorionic Gonadotropin (HCG) Market Revenue and Growth Rate, 2017-2025
3.3.3.Animal Chorionic Gonadotropin Market Revenue and Growth Rate, 2017-2025
3.4.GLOBAL CHORIONIC GONADOTROPIN MARKET PRODUCTION BY TYPE, 2017-2025
3.4.1.Global Chorionic Gonadotropin Market Production (Volume) and Share (%) By Type, 2017-2025
3.4.2.Human Chorionic Gonadotropin (HCG) Market Production and Growth Rate, 2017-2025
3.4.3.Animal Chorionic Gonadotropin Market Production and Growth Rate, 2017-2025
CHAPTER 4.GLOBAL CHORIONIC GONADOTROPIN MARKET BY APPLICATION, 2017-2025
4.1.RESEARCH INSTITUTIONS
4.2.PHARMACEUTICAL
4.3.OTHERS
4.4.GLOBAL CHORIONIC GONADOTROPIN MARKET REVENUE BY APPLICATION, 2017-2025
4.4.1.Global Chorionic Gonadotropin Market Revenue (Million USD) and Share (%) By Application, 2017-2025
4.4.2.Research institutions Market Revenue and Growth Rate, 2017-2025
4.4.3.Pharmaceutical Market Revenue and Growth Rate, 2017-2025
4.4.4.Others Market Revenue and Growth Rate, 2017-2025
4.5.GLOBAL CHORIONIC GONADOTROPIN MARKET CONSUMPTION BY APPLICATION, 2017-2025
4.5.1.Global Chorionic Gonadotropin Market Consumption (Volume) and share (%) By Application, 2017-2025
4.5.2.Research institutions Market Consumption and Growth Rate, 2017-2025
4.5.3.Pharmaceutical Market Consumption and Growth Rate, 2017-2025
4.5.4.Others Market Consumption and Growth Rate, 2017-2025
CHAPTER 5.GLOBAL CHORIONIC GONADOTROPIN MARKET BY TECHNOLOGY, 2017-2025
5.1.NATURAL SOURCE EXTRACTION
5.2.RECOMBINANT DNA TECHNOLOGY
CHAPTER 6.GLOBAL CHORIONIC GONADOTROPIN MARKET BY THERAPEUTIC AREA, 2017-2025
6.1.FEMALE INFERTILITY TREATMENT
6.2.OLIGOSPERMIA TREATMENT
6.3.CRYPTORCHIDISM TREATMENT
6.4.OTHERS
CHAPTER 7.GLOBAL CHORIONIC GONADOTROPIN MARKET BY REGION, 2017-2025
7.1.NORTH AMERICA
7.1.1.U.S.
7.1.2.Canada
7.1.3.Mexico
7.2.EUROPE
7.2.1.U.K.
7.2.2.France
7.2.3.Germany
7.2.4.Italy
7.2.5.Spain
7.2.6.Rest of Europe
7.3.ASIA PACIFIC
7.3.1.China
7.3.2.Japan
7.3.3.India
7.3.4.Korea
7.3.5.Rest of APAC
7.4.SOUTH AMERICA
7.4.1.Brazil
7.4.2.Rest of South America
7.5.REST OF THE WORLD
7.5.1.Middle East
7.5.2.Africa
7.6.GLOBAL CHORIONIC GONADOTROPIN MARKET REVENUE BY REGION, 2017-2025
7.6.1.Global Chorionic Gonadotropin Market Revenue (Million USD) and Share (%) By Region, 2017-2025
7.6.2.North America Market Revenue and Growth Rate, 2017-2025
7.6.3.Europe Market Revenue and Growth Rate, 2017-2025
7.6.4.Asia Pacific Market Revenue and Growth Rate, 2017-2025
7.6.5.South America Market Revenue and Growth Rate, 2017-2025
7.6.6.Rest of the World Market Revenue and Growth Rate, 2017-2025
CHAPTER 8.GLOBAL CHORIONIC GONADOTROPIN MARKET PRODUCTION AND CONSUMPTION ANALYSIS BY REGION, 2017-2025
8.1.GLOBAL CHORIONIC GONADOTROPIN MARKET PRODUCTION ANALYSIS BY REGION, 2017-2025
8.1.1.Global Chorionic Gonadotropin Market Production (Volume) and Share (%) By Region, 2017-2025
8.1.2.Global Chorionic Gonadotropin Market Consumption (Volume) and Share (%) By Region, 2017-2025
8.1.3.North America Market Production and Consumption, 2017-2025
8.1.4.Europe Market Production and Consumption, 2017-2025
8.1.5.Asia Pacific Market Production and Consumption, 2017-2025
8.1.6.South America Market Production and Consumption, 2017-2025
8.1.7.Rest of the World Market Production and Consumption, 2017-2025
CHAPTER 9.MARKET DETERMINANTS
9.1.MARKET DRIVERS
9.2.MARKET RESTRAINTS
9.3.MARKET OPPORTUNITIES
9.4.MARKET DETERMINANTS RADAR CHART
CHAPTER 10.GLOBAL CHORIONIC GONADOTROPIN MARKET COMPETITION BY MANUFACTURERS
10.1.GLOBAL CHORIONIC GONADOTROPIN PRODUCTION AND SHARE BY MANUFACTURERS (2017-2025)
10.1.1.Global Chorionic Gonadotropin Production (VOLUME) and Share (%) by Manufacturers (2017-2025)
10.2.GLOBAL CHORIONIC GONADOTROPIN REVENUE AND SHARE BY MANUFACTURERS (2017-2025)
10.2.1.Global Chorionic Gonadotropin Revenue (Million USD) and Share (%) by Manufacturers (2017-2025)
10.3.CHORIONIC GONADOTROPIN MARKET COMPETITIVE SITUATION AND TRENDS
10.3.1.Chorionic Gonadotropin Market Share (%) of Top 3 Manufacturers
10.3.2.Chorionic Gonadotropin Market Share (%) of Top 5 Manufacturers
CHAPTER 11.GLOBAL CHORIONIC GONADOTROPIN MANUFACTURERS ANALYSIS
11.1.EMD SERONO, INC.
11.1.1.Business Overview
11.1.2.Company Basic Information
11.1.3.Chorionic Gonadotropin Product Details
11.1.4.EMD Serono, Inc. Chorionic Gonadotropin Production, Revenue and Gross Margin
11.2.FERRING B.V.
11.2.1.Business Overview
11.2.2.Company Basic Information
11.2.3.Chorionic Gonadotropin Product Details
11.2.4.Ferring B.V. Chorionic Gonadotropin Production, Revenue and Gross Margin
11.3.MERCK & CO., INC.
11.3.1.Business Overview
11.3.2.Company Basic Information
11.3.3.Chorionic Gonadotropin Product Details
11.3.4.Merck & Co., Inc. Chorionic Gonadotropin Production, Revenue and Gross Margin
11.4.BRISTOL MYERS SQUIBB COMPANY
11.4.1.Business Overview
11.4.2.Company Basic Information
11.4.3.Chorionic Gonadotropin Product Details
11.4.4.Bristol Myers Squibb Company Chorionic Gonadotropin Production, Revenue and Gross Margin
11.5.FRESENIUS KABIUSA, LLC.
11.5.1.Business Overview
11.5.2.Company Basic Information
11.5.3.Chorionic Gonadotropin Product Details
11.5.4.Fresenius KabiUSA, LLC. Chorionic Gonadotropin Production, Revenue and Gross Margin
11.6.SCRIPPSLABS
11.6.1.Business Overview
11.6.2.Company Basic Information
11.6.3.Chorionic Gonadotropin Product Details
11.6.4.Scrippslabs Chorionic Gonadotropin Production, Revenue and Gross Margin
11.7.LEEBIO
11.7.1.Business Overview
11.7.2.Company Basic Information
11.7.3.Chorionic Gonadotropin Product Details
11.7.4.Leebio Chorionic Gonadotropin Production, Revenue and Gross Margin
11.8.KAMIYA BIOMEDICAL COMPANY
11.8.1.Business Overview
11.8.2.Company Basic Information
11.8.3.Chorionic Gonadotropin Product Details
11.8.4.Kamiya Biomedical Company Chorionic Gonadotropin Production, Revenue and Gross Margin
11.9.CIGNA
11.9.1.Business Overview
11.9.2.Company Basic Information
11.9.3.Chorionic Gonadotropin Product Details
11.9.4.Cigna Chorionic Gonadotropin Production, Revenue and Gross Margin
11.10.SANZYME
11.10.1.Business Overview
11.10.2.Company Basic Information
11.10.3.Chorionic Gonadotropin Product Details
11.10.4.Sanzyme Chorionic Gonadotropin Production, Revenue and Gross Margin
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
